[GASMSIA] QoQ TTM Result on 30-Jun-2023 [#2]

Stock
[GASMSIA] GAS MALAYSIA BERHAD
Announcement Date
21-Aug-2023
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2023
Quarter
30-Jun-2023 [#2]
Profit Trend
QoQ- -2.42%
YoY- 16.19%
Quarter Report
Latest QR
Upcoming QR
GASMSIA's Result
GASMSIA's Financial Summary
View:
Show?
TTM Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 7,511,718 8,078,921 8,500,672 8,548,673 8,305,026 7,649,364 7,366,553 1.30%
PBT 523,674 513,716 514,571 540,816 553,023 546,720 495,205 3.79%
Tax -132,739 -130,319 -140,279 -157,023 -159,701 -157,177 -131,593 0.57%
NP 390,935 383,397 374,292 383,793 393,322 389,543 363,612 4.94%
-
NP to SH 390,935 383,397 374,292 383,793 393,322 389,543 363,612 4.94%
-
Tax Rate 25.35% 25.37% 27.26% 29.03% 28.88% 28.75% 26.57% -
Total Cost 7,120,783 7,695,524 8,126,380 8,164,880 7,911,704 7,259,821 7,002,941 1.11%
-
Net Worth 1,250,615 1,367,845 1,263,456 1,252,798 1,157,525 1,278,350 1,182,949 3.77%
Dividend
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Div 181,557 181,557 179,246 179,246 181,557 181,557 152,796 12.17%
Div Payout % 46.44% 47.35% 47.89% 46.70% 46.16% 46.61% 42.02% -
Equity
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Net Worth 1,250,615 1,367,845 1,263,456 1,252,798 1,157,525 1,278,350 1,182,949 3.77%
NOSH 1,284,000 1,284,000 1,284,000 1,284,000 1,284,000 1,284,000 1,284,000 0.00%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin 5.20% 4.75% 4.40% 4.49% 4.74% 5.09% 4.94% -
ROE 31.26% 28.03% 29.62% 30.63% 33.98% 30.47% 30.74% -
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
RPS 585.02 629.20 662.05 665.78 646.81 595.74 573.72 1.30%
EPS 30.45 29.86 29.15 29.89 30.63 30.34 28.32 4.94%
DPS 14.14 14.14 13.96 13.96 14.14 14.14 11.90 12.17%
NAPS 0.974 1.0653 0.984 0.9757 0.9015 0.9956 0.9213 3.77%
Adjusted Per Share Value based on latest NOSH - 1,284,000
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
RPS 584.79 628.95 661.78 665.52 646.55 595.50 573.49 1.30%
EPS 30.43 29.85 29.14 29.88 30.62 30.33 28.31 4.92%
DPS 14.13 14.13 13.95 13.95 14.13 14.13 11.90 12.12%
NAPS 0.9736 1.0649 0.9836 0.9753 0.9011 0.9952 0.9209 3.77%
Price Multiplier on Financial Quarter End Date
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Date 29/03/24 29/12/23 29/09/23 30/06/23 31/03/23 30/12/22 30/09/22 -
Price 3.47 3.21 3.04 3.00 3.16 3.26 3.25 -
P/RPS 0.59 0.51 0.46 0.45 0.49 0.55 0.57 2.32%
P/EPS 11.40 10.75 10.43 10.04 10.32 10.75 11.48 -0.46%
EY 8.77 9.30 9.59 9.96 9.69 9.31 8.71 0.45%
DY 4.07 4.40 4.59 4.65 4.47 4.34 3.66 7.32%
P/NAPS 3.56 3.01 3.09 3.07 3.51 3.27 3.53 0.56%
Price Multiplier on Announcement Date
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Date 24/05/24 20/02/24 28/11/23 21/08/23 18/05/23 17/02/23 17/11/22 -
Price 3.58 3.38 3.14 3.02 3.20 3.34 3.40 -
P/RPS 0.61 0.54 0.47 0.45 0.49 0.56 0.59 2.24%
P/EPS 11.76 11.32 10.77 10.10 10.45 11.01 12.01 -1.39%
EY 8.50 8.83 9.28 9.90 9.57 9.08 8.33 1.35%
DY 3.95 4.18 4.45 4.62 4.42 4.23 3.50 8.38%
P/NAPS 3.68 3.17 3.19 3.10 3.55 3.35 3.69 -0.18%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment